Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aberrant Expression of OX1 Receptors for Orexins in Colon Cancers and Liver Metastases: an Openable Gate to Apoptosis
Thierry Voisin, Aadil El Firar, Magali Fasseu, et al.
Cancer Research (2011) Vol. 71, Iss. 9, pp. 3341-3351
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

An Insight into GPCR and G-Proteins as Cancer Drivers
Preeti Kumari Chaudhary, Soochong Kim
Cells (2021) Vol. 10, Iss. 12, pp. 3288-3288
Open Access | Times Cited: 145
Orexin/hypocretin receptor signalling cascades
Jyrki P. Kukkonen, Christopher S. Leonard
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 314-331
Open Access | Times Cited: 180
Orexin receptors: Multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders
Tian‐Rui Xu, Yang Yang, Richard J. Ward, et al.
Cellular Signalling (2013) Vol. 25, Iss. 12, pp. 2413-2423
Closed Access | Times Cited: 142
Physiology of the orexinergic/hypocretinergic system: a revisit in 2012
Jyrki P. Kukkonen
AJP Cell Physiology (2012) Vol. 304, Iss. 1, pp. C2-C32
Closed Access | Times Cited: 133
Orexin/hypocretin receptor signalling: a functional perspective
Christopher S. Leonard, Jyrki P. Kukkonen
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 294-313
Open Access | Times Cited: 126
The hypocretin (orexin) system: from a neural circuitry perspective
Shi‐Bin Li, Luı́s de Lecea
Neuropharmacology (2020) Vol. 167, pp. 107993-107993
Closed Access | Times Cited: 111
G protein-coupled receptors as promising cancer targets
Ying Liu, Su An, Richard J. Ward, et al.
Cancer Letters (2016) Vol. 376, Iss. 2, pp. 226-239
Closed Access | Times Cited: 107
GPCRs and cancer
Rosamaria Lappano, Marcello Maggiolini
Acta Pharmacologica Sinica (2012) Vol. 33, Iss. 3, pp. 351-362
Open Access | Times Cited: 103
Heteromultimerization of Cannabinoid CB1 Receptor and Orexin OX1 Receptor Generates a Unique Complex in Which Both Protomers Are Regulated by Orexin A
Richard J. Ward, John D. Pediani, Graeme Milligan
Journal of Biological Chemistry (2011) Vol. 286, Iss. 43, pp. 37414-37428
Open Access | Times Cited: 91
Investigation of the roles of exosomes in colorectal cancer liver metastasis
Xia Wang, Xiaoling Ding, Lijuan Nan, et al.
Oncology Reports (2015) Vol. 33, Iss. 5, pp. 2445-2453
Open Access | Times Cited: 89
Orexin/Hypocretin Signaling
Jyrki P. Kukkonen
Current topics in behavioral neurosciences (2016), pp. 17-50
Open Access | Times Cited: 67
Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases
Alain Couvineau, Thierry Voisin, Pascal Nicole, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 63
NECTIN-4 increased the 5-FU resistance in colon cancer cells by inducing the PI3K–AKT cascade
Dipon Das, Shakti Ranjan Satapathy, Sumit Siddharth, et al.
Cancer Chemotherapy and Pharmacology (2015) Vol. 76, Iss. 3, pp. 471-479
Closed Access | Times Cited: 46
β-Arrestin 1 has an essential role in neurokinin-1 receptor-mediated glioblastoma cell proliferation and G2/M phase transition
Yixin Zhang, Xiaofang Li, Guoqiang Yuan, et al.
Journal of Biological Chemistry (2017) Vol. 292, Iss. 21, pp. 8933-8947
Open Access | Times Cited: 44
Focus on the Complex Interconnection between Cancer, Narcolepsy and Other Neurodegenerative Diseases: A Possible Case of Orexin-Dependent Inverse Comorbidity
Maria P. Mogavero, Alessandro Silvani, Lourdes M. DelRosso, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2612-2612
Open Access | Times Cited: 28
The Orexin receptors: Structural and anti-tumoral properties
Alain Couvineau, Pascal Nicole, Valérie Gratio, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 20
The role of innate immune-stimulated epithelial apoptosis during gastrointestinal inflammatory diseases
Richard H. Siggers, David J. Hackam
Cellular and Molecular Life Sciences (2011) Vol. 68, Iss. 22, pp. 3623-3634
Open Access | Times Cited: 47
Impact of Orexin-A Treatment on Food Intake, Energy Metabolism and Body Weight in Mice
Anne Blais, Gaëtan Drouin, Catherine Chaumontet, et al.
PLoS ONE (2017) Vol. 12, Iss. 1, pp. e0169908-e0169908
Open Access | Times Cited: 39
The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role
Alain Couvineau, Stéphanie Dayot, Pascal Nicole, et al.
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 32
Bidirectional gut-brain communication: A role for orexin-A
Cristina Mediavilla
Neurochemistry International (2020) Vol. 141, pp. 104882-104882
Closed Access | Times Cited: 30
Neuropeptides in Cancer: Friend and Foe?
Yue Wu, Adrian Berisha, Jeremy C. Borniger
Advanced Biology (2022) Vol. 6, Iss. 9
Closed Access | Times Cited: 16
Physiological Role of Orexin/Hypocretin in the Human Body in Motivated Behavior: A Comprehensive Review
Rahul Singh, Dalia Biswas
Cureus (2023)
Open Access | Times Cited: 9
Orexin A Suppresses the Growth of Rat C6 Glioma Cells via a Caspase-Dependent Mechanism
Kaja Biegańska, Paulina Sokołowska, Olaf Jöhren, et al.
Journal of Molecular Neuroscience (2012) Vol. 48, Iss. 3, pp. 706-712
Open Access | Times Cited: 36
Protective effect of orexin-A on 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells
Saeed Esmaeili‐Mahani, Somayeh Vazifekhah, Hamzeh Pasban-Aliabadi, et al.
Neurochemistry International (2013) Vol. 63, Iss. 8, pp. 719-725
Closed Access | Times Cited: 36
The orexin type 1 receptor is overexpressed in advanced prostate cancer with a neuroendocrine differentiation, and mediates apoptosis
David Alexandre, Coralie Hautot, Marwa Mehio, et al.
European Journal of Cancer (2014) Vol. 50, Iss. 12, pp. 2126-2133
Closed Access | Times Cited: 34
Page 1 - Next Page

Scroll to top